Press Releases on August 10, 2020 - EIN Presswire - Press Release Distribution Service

Published on August 10, 2020 - 12:00 GMT

Protech Home Medical Announces DTC Eligibility for Its Common Shares

CINCINNATI, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (the “Company” or “Protech”) (TSXV: PTQ) (OTCQX: PTQQF), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is pleased to announce …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on August 10, 2020 - 12:00 GMT

LogicMonitor is Great Place to Work-Certified™ for Second Consecutive Year

SANTA BARBARA, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) -- LogicMonitor, the leading cloud-based IT infrastructure monitoring and observability platform, today announced that it is once again Great Place to Work-Certified™. This is the second consecutive …

Distribution channels: IT Industry, Media, Advertising & PR

Published on August 10, 2020 - 12:00 GMT

Versus Systems Enters Health and Wellness Sector With ePlay Digital

LOS ANGELES, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Versus Systems, Inc. (Versus) (CSE:VS) (OTCQB:VRSSF) (FRANKFURT:BMVA) today announced a partnership with ePlay Digital Inc. (CSE:EPY) (OTC:EPYFF) (FSE:2NY2), an award-winning Augmented Reality studio, to bring …

Distribution channels: Companies, Technology ...

Published on August 10, 2020 - 12:00 GMT

Sustainable Green Team, Ltd. (SGTM) Reports Over $12.3 Million in Revenue and $3.4 Million in Gross Profit for the 2nd Quarter ...

ORLANDO, Fla, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Sustainable Green Team, Ltd. (OTC: SGTM) (“SGTM” or the “Company”), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, today announces another successful quarter, …

Distribution channels: Waste Management

Published on August 10, 2020 - 12:00 GMT

Krystal Biotech Reports Second Quarter 2020 Financial Results and Provides Update on Operational Progress

Initiated the pivotal GEM-3 clinical study evaluating B-VEC in DEB patients Today announced enrollment of 1st patient in Phase 2 clinical study evaluating KB105 in ARCI patients On track to initiate Phase 1 trial of KB301 for an aesthetic indication …

Distribution channels: Business & Economy, Technology ...

Published on August 10, 2020 - 12:00 GMT

Enphase Energy Powers Commercial Business for REAL Solar of Minneapolis

FREMONT, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company and the world's leading supplier of solar microinverters, today announced that REAL Solar, SBC is expanding its portfolio of …

Distribution channels:

Published on August 10, 2020 - 12:00 GMT

Aben Field Program Update

VANCOUVER, British Columbia, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Aben Resources Ltd. (TSX-V: ABN) (OTCBB: ABNAF) (Frankfurt: E2L2) (the “Aben or the Company”) is pleased to announce that the 2020 field season is proceeding well and will be moving into the …

Distribution channels: Media, Advertising & PR, Mining Industry ...

Published on August 10, 2020 - 12:00 GMT

Dominion Aesthetic Technologies, Inc. Enters New Stage of Growth

SAN ANTONIO, Texas, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Dominion Aesthetic Technologies, Inc. (Dominion) announces a new stage of growth for the Texas-based aesthetic medical device company. The company will focus on operational and commercialization …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on August 10, 2020 - 12:00 GMT

Profound Medical Present at the Canaccord Genuity 40th Annual Growth Conference

TORONTO, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”), thermal …

Distribution channels:

Published on August 10, 2020 - 12:00 GMT

Patriot One Appoints Karen Hersh as Chief Financial Officer

TORONTO, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), developer of the PATSCANTM Multi-Sensor Threat Detection Platform, is pleased to announce the appointment …

Distribution channels: Companies, Technology ...

Published on August 10, 2020 - 12:00 GMT

AirBoss to Present at Canaccord Genuity’s 40th Annual Growth Conference

NEWMARKET, Ontario, Aug. 10, 2020 (GLOBE NEWSWIRE) -- AirBoss of America Corp. (TSX: BOS) (the "Company" or "AirBoss"), announced today that President and COO Chris Bitsakakis will present at Canaccord Genuity’s 40th Annual Growth …

Distribution channels: Media, Advertising & PR

Published on August 10, 2020 - 12:00 GMT

Avadel Pharmaceuticals Reports Second Quarter 2020 Financial Results and Recent Business Update

Presented positive topline data from the pivotal Phase 3 REST-ON study Announced today that results of the data analyses for the secondary endpoints of the REST-ON study were consistent with the primary analyses and further demonstrated the overall …

Distribution channels:

Published on August 10, 2020 - 12:00 GMT

Cytta Corp. Sells Additional SUPR Stream Units to UK MOD Advanced Technology Research Group

Las Vegas , Aug. 10, 2020 (GLOBE NEWSWIRE) -- -- Cytta Corp (OTCPINK: CYCA) Cytta Corp has sold a new round of SUPR Stream units to the Electronic Warfare and Surveillance development group within the British Ministry of Defense (UK MOD). This group is …

Distribution channels:

Published on August 10, 2020 - 12:00 GMT

Vaxart Announces IND Filed for COVID-19 Vaccine

SOUTH SAN FRANCISCO, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that its COVID-19 …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on August 10, 2020 - 12:00 GMT

Ovid Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Announces completion of enrollment in the pivotal Phase 3 NEPTUNE trial with OV101 in Angelman syndrome; topline results expected in Q4 2020 Multiple data readouts for soticlestat expected in Q3 2020, including from the randomized Phase 2 ELEKTRA trial in …

Distribution channels: Business & Economy, Technology ...

Published on August 10, 2020 - 12:00 GMT

AnaptysBio Reports Top-Line Data from Interim Analysis of ECLIPSE Phase 2 Clinical Trial of Etokimab in Chronic Rhinosinusitis ...

Etokimab q4w and q8w treatment arms failed to achieve NPS and SNOT-22 statistical significance over placebo at this week 8 interim analysis Secondary analyses demonstrated NPS and blood eosinophil level improvement in both asthma and non-asthma comorbid …

Distribution channels: Science, Technology ...

Published on August 10, 2020 - 12:00 GMT

Bionano Featured at Cancer Genomics Consortium Annual Meeting with Multiple Data Readouts that Further Validate Saphyr in the ...

In a new study at Children’s Hospital of Los Angeles evaluating children with B-ALL, the most common type of cancer in children, researchers using Saphyr discovered an oncogenic variation that they believe may cause the disease in some patients and could …

Distribution channels: Media, Advertising & PR ...

Published on August 10, 2020 - 12:00 GMT

US FDA Approves Spectral Medical’s Protocol Amendment for TIGRIS

Protocol Amendment allows for increase in TIGRIS sites to 15 while potentially accelerating patient enrolling and offsetting any COVID-19 pandemic-related delays TORONTO, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on August 10, 2020 - 12:00 GMT

Neovasc Announces US$12.6 Million Registered Direct Offering Priced At-the-Market

VANCOUVER, CANADA, Aug. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN / TSX: NVCN) announced today that it has entered into definitive agreements with certain healthcare-focused institutional …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR

Published on August 10, 2020 - 12:00 GMT

Enlivex Announces Dosing of First Patient in Clinical Trial of Allocetra in COVID-19 Patients with Severe Illness Respiratory ...

Nes Ziona, Israel, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that the first patient has been dosed in an investigator-initiated multi-center clinical trial of …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...